RxDoctor Payments Data

Nicole Villa, PA

Physician Assistant · Litchfield Park, AZNPI 1639225840

Payments from drug & device makers

$3,121in general payments, 2019–2025

Across 73 payments — averaging $42.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Teleflex LLC$318
  • Astellas Pharma US Inc$205
  • Tolmar, Inc.$117
  • Progenics Pharmaceuticals, Inc.$108
  • Coloplast$104
  • plus $350 from 10 others

What the payments were for

  • Travel & lodging$1,15637%
  • Food & beverage$1,91161%
  • Education$532%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,121 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$24,490
Medicare patients
153
Services billed
1,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron36$30,192
GemtesaVibegron22$22,394
Methenamine Hippurate82$5,282
Potassium Citrate ErPotassium Citrate43$4,842
Tamsulosin Hcl201$3,555
Estradiol53$3,221
Trospium Chloride44$2,341
Testosterone17$2,197
Alfuzosin Hcl ErAlfuzosin Hcl89$2,095
Trimethoprim17$1,487
Solifenacin Succinate54$1,290
Testosterone Cypionate26$940
Finasteride51$831
Ciprofloxacin Hcl95$573
Dutasteride12$532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$205$30,19236 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Litchfield Park

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →